BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
Thymosin Alpha-1, produkto nuotrauka

Laboratorijos ataskaita

PDF
99%
Grynumas
Ištirta
Thymosin Alpha-1 5mg
Laboratorija
Analiza Białek
Data
November 2026
Rezultatas
99% purity (5.33 mg measured)
Endotoksinai
4.56 EU/vial
Užsakymo nr.
Slaptažodis

Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.

Immune System

Thymosin Alpha-1

Immune System

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Trumpai

Thymosin Alpha-1 skaičiais

Pagrindiniai rodikliai iš mūsų žinyno.

Visas žinyno įrašas
Class
Immune-modulating peptidethymus-derived
Frequency
~2x per weekin phases
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 10 mg2 sizes in the shop

Žinios

Viskas apie Thymosin Alpha-1

Pravers

Ko dar jums reikės

Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.

Insulino švirkštai

10 vnt. · 5.50 €

Spiritinės servetėlės

50 vnt. · 10 €

Kiek vandens?

Vienetai ant švirkšto jūsų flakono dydžiui.

Atidaryti skaičiuoklę →

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

Is Thymosin Alpha-1 approved?

Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.

How does Thymosin Alpha-1 work?

In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.

What do the sepsis trials show?

In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.

Are there data on cancer?

In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.

Does it help in severe pancreatitis?

Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.

Which side effects are known?

In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.

Susiję

Susiję produktai